FDA Adverse Event Death Summary report: N

GORE® TAG® THORACIC ENDOPROSTHESIS

MDR report key: 3761139 · Received April 21, 2014

Report

Report Number
2017233-2014-00193
Event Type
Death
Date Received
April 21, 2014
Date of Event
March 18, 2014
Report Date
March 24, 2014
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P040043
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION DETERMINED THERE IS NO ALLEGATION AGAINST THE TAG3410/9910927 USED IN THIS PROCEDURE, WHEREBY THIS MEDWATCH SUBMITTED ON APRIL 19, 2014 IS HEREBY RETRACTED.

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICE(S) VERIFIED THAT THE LOT(S) MET ALL PRE-RELEASE SPECIFICATIONS. THE INSTRUCTIONS FOR USE (IFU) FOR THE GORE AG THORACIC ENDOPROSTHESIS STATES, THE SAFETY AND EFFECTIVENESS OF THE GORE TAG THORACIC ENDOPROSTHESIS HAS NOT BEEN EVALUATED IN THE FOLLOWING PATIENT POPULATIONS: PENETRATING ULCERS, GENETIC CONNECTIVE TISSUE DISEASE.

Description of Event or Problem · 1

ON (B)(6) 2014, THIS PATIENT UNDERWENT TREATMENT FOR A PENETRATING AORTIC ULCER AND WAS IMPLANTED WITH A GORE TAG THORACIC ENDOPROSTHESIS, A GORE DRYSEAL SHEATH WAS USED FOR ADVANCEMENT. NO REPORTED ACCESS OR ADVANCEMENT ISSUES WERE ENCOUNTERED BY THE PHYSICIAN. INTRAOPERATIVELY, THE PATIENT SUFFERED A RUPTURE OF THE RIGHT EXTERNAL ILIAC ARTERY. THE RIGHT COMMON AND INTERNAL ILIAC ARTERIES WERE LIGATED AND A FEMORO-FEMORAL BYPASS WAS PERFORMED. THE PATIENT TOLERATED THE PROCEDURE. THERE WERE NO REPORTED ACCESS ISSUES. THE PHYSICIAN REPORTS THAT THE RUPTURED ILIAC ARTERY WAS CAUSED BY ATHEROSCLEROTIC DISEASE AND SYSTEMIC LUPUS ERIMATOSE. THE PATIENT WAS REPORTED TO HAVE SUFFERED 2000ML BLOOD LOSS. ON (B)(6) 2014, THE PATIENT DIED. THE CAUSE OF DEATH WAS REPORTED TO BE HYPOVOLEMIC SHOCK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
241135 GORE® TAG® THORACIC ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES 9910927

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| L| O| R